Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

11.61
Delayed Data
As of Mar 27
 +0.36 / +3.20%
Today’s Change
4.13
Today|||52-Week Range
12.50
+2.74%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues13.0M27.8M28.0M33.9M
 
 
 
 
 
Depreciation And Amortization886.0K1.4M570.0K412.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses35.7M40.4M51.2M38.6M
 
 
 
 
 
Research And Development30.3M33.8M43.6M30.7M
 
 
 
 
 
Total Operating Expenses36.5M41.7M51.7M39.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-23.5M-13.9M-23.7M-5.1M
 
 
 
 
 
Interest Expense On Debt4.5M4.6M4.6M4.6M
 
 
 
 
 
Other Expenses236.0K161.0K265.0K151.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-27.8M-18.3M-28.0M-9.5M
 
 
 
 
 
Minority Interest-169.0K-181.0K-137.0K-219.0K
 
 
 
 
 
Net Income-27.6M-18.1M-27.9M-9.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS102.9M103.8M104.9M106.7M
 
 
 
 
 
Shares To Calculate EPS Diluted102.9M103.8M104.9M106.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.27-$0.17-$0.27-$0.09
 
 
 
 
 
EPS Diluted-$0.27-$0.17-$0.27-$0.09
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account